Speaker Profile
PhD, Professor, Stanford
Biography
Dr. Scott is a Professor in the Department of Pathology at Stanford University and Director of the Stanford Medicine Clinical Genomics Laboratory, where he oversees genomic test innovation and implementation. In addition, Dr. Scott is certified by the American Board of Medical Genetics and Genomics (ABMGG) in Clinical Molecular Genetics and Genomics, and Clinical Cytogenetics, and his research interests include human genomics, pharmacogenomics, cytogenomics, long read sequencing, and the implementation of genomic medicine. He is a member of the Clinical Pharmacogenetics Implementation Consortium (CPIC), PharmGKB, PharmCAT, PharmVar, AMP Pharmacogenomics Working Group, International Union of Basic and Clinical Pharmacology (IUPHAR), and other national human genomics consortia (ClinGen, UDN, GREGoR). He has co authored several CPIC practice guidelines and has published over 140 peer reviewed manuscripts and book chapters on clinical genomics, pharmacogenomics, and genomic medicine implementation.
Session Abstract – PMWC 2024 Silicon Valley
Track Chair:
Kelly E. Caudle, St. Jude
The PMWC 2024 Pharmacogenomics (PGx) Track focuses on advancing standardization in pharmacogenomics to achieve better clinical outcomes. The importance of standardization in PGx cannot be overstated as it can help to improve patient care in several ways. Standardization of clinical laboratory processes can help ensure consistent and accurate test results, which is crucial for making informed clinical decisions. Standardization of reporting can help to ensure that test results are communicated in a clear and understandable manner to clinicians and patients. Standardization of pharmacogenomic test ordering and reimbursement can help to ensure that patients have access to the tests they need, regardless of their location or financial situation. Standardization of PGx education can help to ensure that healthcare professionals have the knowledge and skills they need to use PGx in clinical practice effectively. Finally, clinical pearls and outcome data can help to demonstrate the value of PGx in improving patient outcomes and informing clinical decision-making.
- PMWC 2024 PGx Award Ceremony:
Pioneer Honoree: Andrea Gaedigk, Children’s Mercy Research Institute (CMRI)
Luminary Honoree: Teri E. Klein, Stanford - Standardization: Key to Advancing Precision Medicine
Opening Talk: Kelly E. Caudle, St. Jude
- Current and Desired States of Standardization of Clinical Laboratory Processes
Chair: Andrea Gaedigk, Children’s Mercy Research Institute (CMRI)
- Vicky Pratt, Agena Bioscience
- FIRESIDE CHAT
Chair: Damon Hostin, Illumina
- Howard McLeod, Utah Tech University
- Current and Desired States of Standardization of Reporting (PANEL)
Chair: Chad Bousman, University of Calgary
- Lisa Brown, Great Scott!
- Vicky Pratt, Agena Bioscience
- Current and Desired States of Standardization of Pharmacogenomic Test Ordering and Reimbursement (PANEL)
Chair: Sara Rogers, American Society of Pharmacovigilance
- Jai Patel, Atrium Health
- Greg Warren, Axene Health Partners - Current and Desired State of PGx Education
Chair: Phil Empey, University of Pittsburgh
- Michelle Whirl Carrillo, Stanford
- Current and Desired State of the Patient Experience in Precision Medicine (PANEL)
Chair: Avni Santani, LetsGetChecked
- Kristy Crooks, University of Colorado - Stuart Scott, Stanford - Clinical Pearls and Outcome Data: Advancing the Adoption of Pharmacogenomics in Clinical Practice
Chair: Kelly E. Caudle, St. Jude
- Larisa H Cavallari, University of Florida
- Jeff Bishop, University of Minnesota - PMWC Showcase
- Bani Tamraz, UCSF
